Pfizer (BUE:PFE) Other Current Liabilities : ARS17,676,493 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Pfizer Other Current Liabilities?

Pfizer's other current liabilities for the quarter that ended in Mar. 2024 was ARS17,676,493 Mil.

Pfizer's quarterly other current liabilities increased from Sep. 2023 (ARS6,700,843 Mil) to Dec. 2023 (ARS8,417,437 Mil) and increased from Dec. 2023 (ARS8,417,437 Mil) to Mar. 2024 (ARS17,676,493 Mil).

Pfizer's annual other current liabilities increased from Dec. 2021 (ARS2,854,987 Mil) to Dec. 2022 (ARS4,356,385 Mil) and increased from Dec. 2022 (ARS4,356,385 Mil) to Dec. 2023 (ARS8,417,437 Mil).

Pfizer Other Current Liabilities Historical Data

The historical data trend for Pfizer's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Other Current Liabilities Chart

Pfizer Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Pfizer Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Pfizer Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Pfizer Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Pfizer's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer (BUE:PFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (BUE:PFE) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK 0Q1N:UK PFE:Germany PFE:Chile PFE:Canada PFIZ34:Brazil PFE:Austria

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.